Clinical Trial Update: Kahn Study; Investigation Of The Efficacy Of Ziprasidone Versus Olanzapine In The Management Of Recent-Onset Psychosis; A Flexible-Dose, Parallel Group, Double-Blind Study [Phase 3]

View source ↗

Summary

A Phase 3 randomized, double-blind trial comparing ziprasidone to olanzapine in recent-onset psychosis (schizophrenia/psychotic disorders) completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psychotic Disorders
• Schizophrenia

Drugs mentioned

• Ziprasidone (ziprasidone)
• olanzapine (olanzapine)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Schizophrenia, Psychotic Disorders | Phase 3 | Status: COMPLETED